Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« The PhD Problem: A Global Perspective | Main | Graphical Crankiness »

April 26, 2011

So Much For Natural-Product Nevirapine

Email This Entry

Posted by Derek

Remember that weird Tetrahedron paper from last December? The one that claimed that it isolated the reverse transcriptase inhibitor nevirapine as a natural product from an Indian plant? In chiral form, no less?

Well, the journal would now like to say "Never mind". The lead author has retracted the paper, "due to doubt created in the scientific community on the origin of nevirapine from the seeds of Cleome viscosa". That's an odd way to put it. Isn't it? Doubts that other people might have are irrelevant if you're right, aren't they?

No, this is similar to the classic weasel-word apology, the one that goes on about regretting the way that some people took offense rather than regretting the original action itself. The reason this paper was retracted, surely, was that those doubts in the scientific community were well-founded. This paper made no sense on several levels, and those problems should have been caught immediately. Its publication was an embarrassment for Tetrahedron and for Elsevier.

I think that the reason I get so worked up about these things is the laziness and sloppy thinking involved. Scientific research deserves more than that, and the rest of us deserve more from the people who publish it.

Comments (5) + TrackBacks (0) | Category: The Scientific Literature


COMMENTS

1. Jose on April 26, 2011 9:32 AM writes...

I can only hope the ghosts of RBW and Robinson come back and kick some editorial a**....

Permalink to Comment

2. Josh on April 26, 2011 10:35 AM writes...

I can't even imagine a sequence of events that would lead to such a result. Unless some idiot actually dropped a pill into the extract.

Permalink to Comment

3. Felix on April 26, 2011 11:03 AM writes...

This is ridiculous - it should have been retracted "because the results were obviously false and our review process failed to catch it".

Permalink to Comment

4. TsOH on April 27, 2011 2:08 AM writes...

My favorite was the NaH-oxidant's "this article was retracted for scientific reasons," but this one is pretty good too.

Permalink to Comment

5. Martin on May 30, 2011 7:21 PM writes...

And another one:

JNP, this week:

"Is 2,3,4,5-Tetramethoxybenzoyl Chloride a Natural Product?"

debunking a paper from
Chen, et al J. Nat. Prod. 2007, 70, 989– 992

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
A Last Summer Day Off
The Early FDA
Drug Repurposing
The Smallest Drugs
Life Is Too Short For Some Journal Feeds
A New Look at Phenotypic Screening
Small Molecules - Really, Really Small
InterMune Bought